Health Monitor: Care for your Gut  |  Education Information: CBSE cancels class 10 Board Exams, postpones Class 12th Board Exams  |  Policy Indications: Dr Harsh Vardhan announces launch of `Aahaar Kranti’  |  Teacher Insights: X or Y? Learning is Beyond Getting the Equations Right!  |  Policy Indications: Atal Innovation Mission collaborates with Bayer  |  Parent Interventions: NITI Aayog Launches‘Poshan Gyan’, a Digital Repository on Nutrition Information  |  Education Information: EdCIL pays a highest ever dividend of Rs 12.5 Crore for the year 2019-20  |  National Edu News: Fitness Challenge for the Nation - 70th RRT Conference Intl. on 16th April  |  Parent Interventions: Reading for Fun Improves Language Skills  |  Technology Inceptions: Xiaomi Redmi Note 10 Pro  |  Technology Inceptions: Canon New image Runner Advance Dx  |  Technology Inceptions: Boat Bar 4000 DA  |  Teacher Insights: Digital Tool to Detect Fake News  |  Science Innovations: HGCO19: starting the enrolment for the PhaseI/II human clinical trials  |  National Edu News: Scientists discover the farthest Gamma-ray emitting active galaxy   |  
April 02, 2020 Thursday 08:39:07 PM IST

DST-SERB announces first set of approved projects to combat CoVID-19

Health Monitor

COVID-19 virus has spread rapidly throughout the world, a crisis which the World Health Organisation has termed as a pandemic. Given the lack of availability of suitable chemotherapeutic interventions and an efficacious vaccine, the global population has been hit hard with utmost vulnerability to the current coronavirus outbreak. In view of increasing the load of CoVID-19 infections in India, the Department of Science and Technology-- Science and Engineering Board (DST-SERB) announced several special research project calls to urgently ramp up national R&D efforts against the epidemic.

The first set of 5 projects has been selected by DST-SERB, which will be supported for further development into implementable technologies. Three of these projects concern the highly important issue of antiviral and virustatic surface coating of inanimate surfaces, such as personal protection equipment (PPE); while another one deals with the identification of metabolite biomarkers in CoVID-19 infected patients enabling therapeutic target identification; and the last one concerns with the development of antibodies against the receptor-binding domain of the spike glycoprotein of coronavirus.The projects were selected after peer-review and assessment by a Special Expert Committee for CoVID-19 projects.

The projects are the following:

Identification of global metabolite biomarkers in CoVID-19 infected patients for targeted therapy


This will identify the global metabolite biomarkers in CoVID-19 infected patients. It will help in search of potential biomarker signature for CoVID infection and recognition of novel targets for therapy.


Development of functionalized inanimate surfaces with repurposable multi-targeted viricidal agents/drugs for preventive and cost-effective antiviral applications

It will help develop viricidal coatings for inanimate surfaces used in healthcare settings such as surgical masks for the prevention of infectious diseases caused by highly contagious pathogens such as severe acute respiratory syndrome-related novel coronavirus, SARS-CoV-2.



Development of antiviral surface coatings to prevent the spread of infections caused by influenza virus

As the attachment of viruses onto surfaces leads to the spread of deadly infections, the objective of the proposal is to develop small molecular and polymeric compounds which will be coated, both covalently as well as non-covalently, on various surfaces and kill respiratory viruses completely upon contact.



Development of formulations for viral decontamination of inanimate surfaces

This will help develop material that may be used as a virus tactic and be applied to mops to disinfect the surfaces to remove any adhering viruses or bacteria.


Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel


This project will help develop antibodies against the receptor-binding domain of the spike glycoprotein of CoV involved in recognizing a host cell-surface receptor, namely, zinc peptidase angiotensin-converting enzyme 2. Another objective is to develop unsaturated free fatty acid-based emulsion loaded in-situ gels to inactivate the virus at the point of entry.

Comments